Triple-Hormone-Receptor Agonist Retatrutide for Obesity – A Phase 2 Trial.
Metadata
- PMID: 37366315
- Authors: Jastreboff AM, Kaplan LM, Frías JP, Wu Q, Du Y et al.
- Journal: N Engl J Med
- Year: 2023
Related Peptides
Key Findings
Triple-Hormone-Receptor Agonist Retatrutide for Obesity – A Phase 2 Trial.
Tags
#research #RCT #evidence-level-I